High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years

Arellano, Martha ; Winton, Elliott ; Pan, Lin ; Lima, Lisa ; Tighiouart, Mourad ; Bhalla, Kapil ; Heffner, Leonard T. ; Neely, Jessica ; Hutcherson, Donald ; McLemore, Morgan ; Langston, Amelia ; Khoury, H. Jean

Cancer, 2012-01, Vol.118 (2), p.428-433 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível